Findings

What do systematic reviews say?

28 questions · 32 findings · 2 reviews · Gynaecological, Neuro-oncology and Orphan Cancer

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 15.6%GRADE not reported 0 · 0%Very low 5 · 15.6%Low 16 · 50%Moderate 6 · 18.8%High 0 · 0%

Probiotics vs other active intervention

Time to rescue medication ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotics vs other active intervention

Adverse events · participants with cancer treated with radiotherapy (with or without chemotherapy)

1 finding from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 211 participants
Very low

Probiotics vs other active intervention

All‐cause mortality · participants with cancer treated with radiotherapy (with or without chemotherapy)

1 finding from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 211 participants
Low

Probiotics vs placebo

Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotics vs placebo

Median (mean) time to use of rescue medication · participants with cancer treated with radiotherapy (with or without chemotherapy)

2 findings from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 205 participants
Moderate
Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 482 participants
Moderate

Probiotics vs placebo

Adverse events · participants with cancer treated with radiotherapy (with or without chemotherapy)

2 findings from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 205 participants
Moderate
Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 902 participants
Low

Probiotics vs placebo

All‐cause mortality · participants with cancer treated with radiotherapy (with or without chemotherapy)

2 findings from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 205 participants
Moderate
Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 902 participants
Low

Probiotics vs placebo or control

Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer

Summary of findings: Probiotics may leads to lower diarrhoea (grade 2+) compared with control (placebo or no intervention) (low certainty).

1 finding from 1 review

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes only
RR 0.43 [0.22, 0.82]
5 studies · 923 participants
Low